欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2021, Vol. 26 ›› Issue (1): 113-120.doi: 10.12092/j.issn.1009-2501.2021.01.015

• 综述与讲座 • 上一篇    

单克隆抗体药物药代动力学特征、分析方法以及体内分析方法学研究进展

朱雪亚,李泽运,田 鑫,张晓坚   

  1. 郑州大学第一附属医院,郑州 450052,河南
  • 收稿日期:2020-07-01 修回日期:2020-12-03 出版日期:2021-01-26 发布日期:2021-02-01
  • 通讯作者: 张晓坚,通信作者,男,博士,主任药师,研究方向:医院药学研究。 Tel: 0371-66295652 E-mail: zhxj0524@sina.com
  • 作者简介:朱雪亚,女,硕士研究生,研究方向:临床药学。 Tel: 18637836790 E-mail: zhuxueya1029@163.com

Research progress of monoclonal antibodies in pharmacokinetic characteristics, analysis methods and method validation

ZHU Xueya, LI Zeyun, TIAN Xin, ZHANG Xiaojian   

  1. Department of Pharmacy, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China
  • Received:2020-07-01 Revised:2020-12-03 Online:2021-01-26 Published:2021-02-01

摘要: 近年来,单克隆抗体药物发展迅速,在肿瘤、免疫、血液等系统疾病领域应用日益广泛。截至2019年其全球处方药物市场占比已达15.3%(1 400亿美元)。单克隆抗体药物作为一种大分子蛋白,因其特殊的结构和生理性质,在体内的吸收、分布、代谢及排泄均与小分子药物存在较大差异,具有靶点介导的药物处置、非线性药动学代谢、时间依赖性、较长的半衰期等独特的药代动力学特征,充分了解这些特征有益于该类药物分析方法的开发。单克隆抗体药物在生物体内的处置具有特殊性和复杂性,极大地增加了生物检测的难度,因此必须建立专属、灵敏、准确、可重复的测定分析方法。本文旨在论述单克隆抗体药物的药代动力学特征、常用分析方法及其优缺点、体内分析方法学验证要求等,并逐点与小分子药物进行对比讨论,以期为单克隆抗体药物的分析技术开发提供部分参考。

关键词: 单克隆抗体类药物, 药代动力学特征, 分析方法, 方法学要求

Abstract: In recent years, monoclonal antibodies (mAbs) have been developing rapidly and widely used in fields of tumor, immunity, blood and other systemic diseases. Global share of mAbs in prescription drug market had reached up to $ 140 billion, 15.3% by 2019. As macromolecule proteins, with special structures and physiological properties, mAbs have great differences in absorption, distribution, metabolism and excretion in vivo compared with small molecule drugs, including characteristics of relatively large molecular mass, high specificity and selectivity in target combination, non-linear pharmacokinetics, time dependence, long half-life and so on. Fully understanding of these special pharmacokinetic characteristics shall effectively guide analysis of mAbs. Meanwhile, the particularity and complexity of disposal mechanism in organisms greatly increase the difficulty of biological detection. As a result, it is necessary to establish exclusive, sensitive, accurate and repeatable quantification methods in biological samples. This article focuses on pharmacokinetic characteristics, main analytical methods, and methodology validation of quantification for mAbs in biological samples, expounding with comparisons of small molecular drugs, so as to prompt development of pharmacokinetic study of this kind of drugs.

Key words: monoclonal antibodies, pharmacokinetics characteristics, analysis method, method validation

中图分类号: